Dynamic intervention-based biomarkers may reduce heterogeneity and motivate targeted interventions in clinical high risk for psychosis

Affiliations

• ¹ Department of Psychiatry, VA Boston Healthcare System, Brockton Division, Brockton, MA, USA; Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
• ² Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
• ³ Department of Psychology, Northeastern University, Boston, MA, USA.
• ⁴ Shanghai Key Laboratory of Psychotic Disorders, SHARP Program, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
• ⁵ Department of Psychology, Florida A&M University, Tallahassee, FL, USA.
• ⁶ Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ⁷ Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ⁸ Shanghai Key Laboratory of Psychotic Disorders, SHARP Program, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: Jijunwang27@163.com.
• ⁹ Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: wstone@bidmc.harvard.edu.